Hyoscini butylbromidum
important information for the patient.
This medicine should always be taken exactly as described in this patient leaflet or
according to the doctor's, pharmacist's, or nurse's instructions.
Hyoscine butylbromide, the active substance of Buscopan, is an antispasmodic.
Antispasmodics reduce spasms of the smooth muscles of the internal organs of the abdominal cavity –
in the digestive tract, bile ducts, urinary system, and female reproductive tract,
which relieves pain.
They are used to relieve colic pain, i.e., pain in the abdominal cavity originating from
the aforementioned internal organs, whose intensity increases and (or) decreases and is difficult
to determine their exact location.
Buscopan can be used in conditions of smooth muscle spasms of the digestive tract
(in functional disorders of the digestive tract, painful stomach spasms, intestinal colic, irritable bowel syndrome), in conditions of spasms and dyskinesia of the bile ducts
(in functional disorders of the bile ducts, acute pain in the bile ducts, biliary colic), in conditions of spasms in the urogenital system (in painful menstruation, renal colic, spasms associated with kidney stone disease).
Particular caution should be exercised in the following circumstances:
The patient should tell their doctor or pharmacist about all medicines they are currently taking
or have recently taken, as well as any medicines they plan to take.
Before starting to take Buscopan, the patient should consult their doctor if they are taking
the following medicines:
The patient should also inform their doctor about taking metoclopramide (used to treat
nausea, vomiting, or gastrointestinal disorders), as the effect of Buscopan and metoclopramide may be reduced.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child,
they should consult their doctor or pharmacist before taking this medicine.
It is recommended to avoid taking Buscopan during pregnancy and breastfeeding.
No studies have been conducted on the effect of the medicine on the ability to drive and use machines.
There are no recommendations for taking Buscopan and driving or using machines.
One coated tablet contains approximately 41.2 mg of sucrose, which corresponds to 411.8 mg of sucrose
in the case of the maximum recommended daily dose. If the patient has previously been diagnosed with intolerance to certain sugars, they should consult their doctor before taking the medicine.
This medicine should always be taken exactly as described in the patient leaflet or according to
the doctor's or pharmacist's instructions. If in doubt, the patient should consult their doctor or pharmacist.
Recommended dose:
unless the doctor recommends otherwise:
children aged 6 to 12 years: 3 times a day, 1 tablet,
adults and children over 12 years: 3 to 5 times a day, 1 or 2 tablets.
Do not exceed the dose of 100 mg per day. Do not use in children under 6 years of age.
Tablets should be swallowed whole, with a drink.
Do not take Buscopan for more than 3 days without consulting a doctor. If the patient needs to take Buscopan continuously or for a longer period, they should consult their doctor to determine the cause of the symptoms.
In children over 6 years of age, Buscopan can be used only with the doctor's consent. In children under 6 years of age, Buscopan is not recommended due to the high content of the active substance.
In case of taking a higher dose of Buscopan than recommended or taking the medicine by a child under 6 years of age, the patient should immediately consult their doctor.
The following symptoms may occur: dry mouth, skin redness, difficulty urinating, rapid heartbeat, and vision disturbances.
In case of missing a dose, the patient should take it as soon as they remember, but they should not take a double dose to make up for the missed dose. The next dose should be taken at the usual time .
Buscopan should be taken only when needed and its use should be stopped after the symptoms have subsided.
If the patient has any further doubts about taking this medicine, they should consult their doctor or pharmacist.
Like all medicines, Buscopan can cause side effects, although not everybody gets them.
Many of the side effects listed below result from the anticholinergic effect of the medicine. They are usually mild and transient.
In addition, the following side effects have been reported:
rapid heartbeat, dry mouth, decreased sweating, skin reactions (hives, itching)
urinary retention
anaphylactic shock (a sudden and severe allergic reaction characterized by difficulty breathing, circulatory collapse, and sudden swelling), anaphylactic reactions with episodes of respiratory disorders, skin reactions (rash, redness), and other hypersensitivity reactions
If any side effects occur, including any side effects not listed in the leaflet, the patient should consult their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products
of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C, 02-222 Warsaw, Tel. (22) 49 21 301, Fax (22) 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, it is possible to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Store at a temperature not exceeding 25°C.
Do not use Buscopan after the expiry date stated on the packaging.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Buscopan is a coated tablet.
Packaging: aluminum/PVC/PVDC or PVC/aluminum blister pack in a cardboard box.
Pack size: 10 coated tablets; 20 coated tablets
Not all pack sizes may be marketed.
IPSEN Consumer HealthCare
65 Quai Georges Gorse
92100 Boulogne-Billancourt
France
Delpharm Reims
10 rue Colonel Charbonneaux
51100 REIMS
France
To obtain more detailed information, the patient should contact the representative of the marketing authorization holder:
MAYOLY POLSKA Sp. z o.o.
ul. Domaniewska 39B
02-672 Warsaw
tel.: 22 166 26 26
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.